Stocktoria
STERIS plc STE
NYSE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-11-03
STERIS plc financials (annual)
Bars are annual figures from 2018 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $5.5B | $5.1B | $4.5B | $4.2B | $3.1B | $3.0B | $2.8B | $2.6B |
| Gross profit | $2.6B | $2.4B | $2.2B | $2.0B | $1.9B | $1.3B | $1.3B | $1.2B | $1.1B |
| R&D expense | $112.9M | $107.6M | $103.7M | $98.5M | $86.7M | $66.3M | $65.5M | $63.0M | $60.8M |
| SG&A expense | $1.4B | $1.3B | $1.3B | $1.1B | $1.3B | $731.3M | $716.7M | $669.9M | $632.0M |
| Operating income | $1.1B | $866.6M | $836.1M | $791.1M | $477.8M | $548.4M | $537.0M | $411.0M | $399.9M |
| Interest expense | — | — | $144.4M | $108.0M | $89.5M | $37.2M | $40.3M | $45.0M | $50.6M |
| Income tax | $262.2M | $184.7M | $149.5M | $124.1M | $82.3M | $120.7M | $90.9M | $64.3M | $63.4M |
| Net income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M | $397.4M | $407.7M | $303.7M | $290.9M |
| EPS (diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 |
| Operating cash flow | $1.3B | $1.1B | $973.3M | $756.9M | $684.8M | $689.6M | $590.6M | $539.5M | $457.6M |
| Free cash flow | $972.4M | $778.0M | $613.0M | $395.0M | $397.2M | $450.4M | $376.0M | $349.8M | $292.2M |
| Cash & equivalents | $439.6M | $171.7M | $207.0M | $208.4M | $348.3M | $220.5M | $319.6M | $220.6M | $201.5M |
| Inventory | $631.8M | $581.3M | $674.5M | $604.4M | $575.0M | $315.1M | $263.5M | $208.2M | $205.7M |
| Total assets | $10.7B | $10.1B | $11.1B | $10.8B | $11.4B | $6.6B | $5.4B | $5.1B | $5.2B |
| Total liabilities | $3.5B | $3.5B | $4.7B | $4.7B | $4.9B | $2.7B | $2.0B | $1.9B | $2.0B |
| Shareholders' equity | $7.2B | $6.6B | $6.3B | $6.1B | $6.5B | $3.9B | $3.4B | $3.2B | $3.2B |
Growth · year-over-year · Revenue CAGR 10.8%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +8.7% | +6.2% | +13.3% | +7.4% | +35.9% | +2.5% | +8.9% | +6.2% | — |
| Net income growth | +27.3% | +62.5% | +253.4% | -56.1% | -38.6% | -2.5% | +34.2% | +4.4% | — |
| EPS growth | +27.9% | +62.7% | +256.1% | -56.9% | -46.4% | -2.7% | +34.1% | +4.7% | — |
| Free cash flow growth | +25.0% | +26.9% | +55.2% | -0.6% | -11.8% | +19.8% | +7.5% | +19.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.